In part 3 of this Exclusive Interview, Tony Galliani talks with Diabetes in Control Publisher Steve Freed about the features of the new smart pen and how it compares to pumps.
Tony Galliani is the National Sales Director at Companion Medical located in San Diego.
Transcript of this video segment:
Freed: So, it’s pretty similar to an insulin pump except you’re not wearing it.
Galliani: Exactly. They’re getting almost all the features of an insulin pump without the cost of a pump; we’re a fraction of the cost of an insulin pump and without having to wear a device. And really we’re doing everything that the pump is doing except we don’t have the ability to vary basal rates, so patients would still be on basal insulin and we don’t extend the bolus. But other than that, I think the most important features of our app being the tracking active insulin, because there’s always that fear of patients have on multiple injections for stacking insulin, so we’re tracking active insulin and we’re deducting that from corrective doses. And then the numeracy part of it, taking the math away. It’s difficult for patients, for most people, to do that math at meal time to figure out how much insulin to give and there’s always that fear that they’re going to give either too much or too little insulin.